PRACTICA OTO-RHINO-LARYNGOLOGICA
Vol. 98 No. 10 October 2005
A Case Report: Experience of Docetaxel (TXT)
Administration in Cancer of the Maxillary Sinus
Shigetoshi Yoda
(Kawasaki Medical School, Japanese Red Cross Society Wakayama Medical Center)
Masako Uno, Teruhito Aihara, Kazuyasu Fukuda,
Takeshi Akisada and Tamotsu Harada
(Kawasaki Medical School)
Tadao Enomoto
(Japanese Red Cross Society Wakayama Medical Center)
Combined therapy for maxillary sinus cancer (operation, chemotherapy and radiation therapy) is a primary modality. Recently, selective-artery intrafusion of CDDP (cisplatin), 5-FU (5-fluorouracil) by using catheter insertion from the superficial temporal artery has become the prevalent chemotherapy. In this case we performed treatment by administering 10 mg of Docetaxel (TXT) once a week instead of CDDP, 5-FU, and obtained an effective result.
Key words : Docetaxel, selective intra-arterial infusion, chemoradiotherapy